These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 210885

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Excitatory nature of dopamine in the nigro-caudate pathway.
    Kitai ST, Sugimori M, Kocsis JD.
    Exp Brain Res; 1976 Feb 26; 24(4):351-63. PubMed ID: 1261623
    [Abstract] [Full Text] [Related]

  • 24. [Excitation and inhibition processes in the neurons of the thalamic motor nuclei of normal cats and following an N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lesion of the nigrostriatal dopaminergic system].
    Voloshin MIa, Lukhanina EP, Kolomiets BP, Burchinskaia LF, Nosenko ND.
    Neirofiziologiia; 1989 Feb 26; 21(5):620-9. PubMed ID: 2557553
    [Abstract] [Full Text] [Related]

  • 25. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R.
    Trans Am Neurol Assoc; 1974 Feb 26; 99():255-7. PubMed ID: 4156892
    [No Abstract] [Full Text] [Related]

  • 26. Glycine enhancement of caudate neuronal activities: relationship with the dopaminergic nigrostriatal pathway.
    Finnerty EP, Chan SH.
    Eur J Pharmacol; 1980 Oct 31; 67(4):477-9. PubMed ID: 7449827
    [Abstract] [Full Text] [Related]

  • 27. Changes in multiunit activity of nigral neurons induced by cholinergic and dopaminergic stimulation of the caudate nucleus.
    Pazo JH, Medina JH.
    Brain Res; 1982 Oct 14; 249(2):301-8. PubMed ID: 6291714
    [Abstract] [Full Text] [Related]

  • 28. Nigro-caudate and caudato-nigral relationship: an electrophysiological study.
    Kitai ST, Wagner A, Precht W, Ono T.
    Brain Res; 1975 Feb 21; 85(1):44-8. PubMed ID: 162839
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The nigro-neostriatal pathway: the effects produced by iontophoretic dopamine.
    Connor JD.
    Res Publ Assoc Res Nerv Ment Dis; 1972 Feb 21; 50():193-206. PubMed ID: 4403651
    [No Abstract] [Full Text] [Related]

  • 32. [Pharmacologic manipulation of the field potential in the caudate nucleus of cats evoked by substantia nigra stimulation].
    Dupelj M, Wagner A.
    Neurologija; 1977 Feb 21; 25(1-2):31-41. PubMed ID: 616874
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM, Zubieta JK, Rezvani AH, Cubeddu LX.
    J Pharmacol Exp Ther; 1990 Feb 21; 252(2):817-25. PubMed ID: 2138224
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects on the caudate spindle in rats of taurine and gamma-aminobutyric acid (GABA) microinjected into the substantia nigra: involvement of the dopaminergic system.
    Okuyama S, Hashimoto S, Aihara H.
    Brain Res; 1985 Sep 09; 342(2):366-8. PubMed ID: 4041839
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists.
    Skirboll LR, Grace AA, Bunney BS.
    Science; 1979 Oct 05; 206(4414):80-2. PubMed ID: 482929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.